Botulinum Toxin Market Growth Statistics, Segmentation, Current Trends, Sales Outlook, COVID-19 Impact and Dynamics By 2025
Research Reports
Dec 29, 2020
Botulinum Toxin Market Landscape
Amid the COVID-19 crisis, the global Botulinum Toxin market is estimated to reach USD 9442.93 Million by 2025. In the future, the market would reach a revised size post Coronavirus pandemic, growing at a CAGR of 10.3% over the period 2016-2025. Market Research Future that has been witnessing the market’s scenario since decades sorts this information, and according to a thorough study, the statistics are presented for a clear understanding of the global Botulinum Toxin market
Botulinum Toxin Market Boomers & Decliners
The intensifying number of non-invasive cosmetic procedures is sorted to motivate the market growth. The primary factor escalating the growth trend in the market is a lofty consciousness amongst individuals regarding their appearance. Growing patient preference towards non-invasive or minimally treatments coupled with the development of new products will thus hasten the market progress.
Request Free Sample Copy of the report “ Global Botulinum Toxin Market Research Report—Forecast till 2025 ” at: https://www.marketresearchfuture.com/sample_request/8567
The escalating quality of care, along with the availability of minimally invasive surgeries by aesthetic surgeons, has contributed to momentous growth in procedural volume. An aging population, intensifying incidence of aesthetic problems such as crow’s feet, lateral canthal lines, and introduction of cost-effective aesthetic products are also boosting the Botulinum toxin market demand.
Adding in this, the focus of market players is to develop and add new products to cosmetic procedures that will further contribute significantly to the market growth in the forecast period. The surged demand for Botulinum toxin products is also driven mainly by expanded safety profiles and the relative longevity of the product offerings. Some of the other factors that are also contributing to the growth of the market are the boost in the geriatric population, and the surged therapeutic indication such as chronic migraine and cervical dystonia.
Furthermore, the preamble of new and advanced Botulinum toxins such as Liztox, developed by a South Korean company Huon’s Global is likely to oblige the market growth in developed as well as emerging countries, during the forecast period, as per MRFR’s study conducted. The recent trend in the healthcare industry is the adoption of combination therapy. Medical practitioners are incorporating Botulinum toxin with other drugs and treatment options in diverse procedures to present long-lasting effects. In the case of point, botulinum toxin combined with aluminum chloride hex hydrate antiperspirant that creates a better response to the treatment in hyperhidrosis patients. Similarly, the use of botulinum toxin with dermal fillers is observed to present a smoother appearance and a more prolonged effect in cosmetic procedures.
On the contrary, the factor such as side effects and lack of reimbursement policies may restrain the industry growth.
Botulinum Toxin Market Segment Review
Depending on the segment of type, the market has included botulinum toxin type A and B. Botulinum toxin type A products are probable to grab a maximum market share of 96.29% during the forecast period. The majority of the products available in the market are botulinum toxin type A products. Dysport (Galderma SA), Botox (Allergan PLC), and Xeomin (Merz Pharma GmbH & Co KGaA) are leading brands of botulinum toxin A type which is grabbing significant market share in the global market.
Depending on the segment of the application, the market has included therapeutic and aesthetic applications. The therapeutic segment is more categorized into spasticity, chronic migraine, overactive bladder, cervical dystonia, blepharospasm, and more.
Depending on the segment of end-user, the market has included Hospitals & Clinics, Dermatology Centers, and others.
Botulinum Toxin Market Regional Outlook
The Americas might command the largest market share owing to the surging rising cases of spasticity, product approvals, and the incidence of major manufacturers such as LLC., US WorldMeds, Hugel, Inc., Evolus, Inc., and Revance Therapeutics, Inc. in the region. Additionally, escalating product approvals and rising incidence of spasticity is possible to encourage the growth of the botulinum toxin market in these countries. In August 2019, US WorldMeds, LLC, a US-based pharmaceutical company, received US FDA sanction for the supplemental biologics license application for Myobloc (rimabotulinumtoxinB) injection for the treatment of chronic sialorrhea.
Europe accounts for the second-largest market for global aesthetics owing to the rising botulinum toxin procedures and the incidence of developed economies such as the UK, Germany, and France. As per the International Society of Aesthetic Plastic Surgery, about 321,702 botulinum toxin procedures were carried out in Germany in the year 2019.
The Asia-Pacific might exhibit the fastest market growth from 2019 to 2025 owing to the increasing geriatric population, developing healthcare infrastructure, rising per capita disposable income, the booming entertainment industry, and medical tourism. In India, as per a report published by United Nations Population Fund (UNFPA), the share of the population above the age of 60 was 8% in the year 2015, and it might reach 19% by 2050. This regional market might expand at a CAGR of 11.01% in the forecast period of 2019 to 2025.
Botulinum Toxin Market Vendors Landscape
The prominent vendors in the global botulinum toxin market are Merz Pharma GmbH & Co KGaA, Daewoong Pharmaceutical Co., Ltd, US WorldMeds, Evolus, Inc., Medytox, and Revance Therapeutics, Inc.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/botulinum-toxin-market-8567
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Tags:
, Reportedtimes, iCN Internal Distribution, Research Newswire, English
YOU MAY ALSO LIKE
PW Consulting Releases Comprehensive Market Research on…
Botulinum Toxin Market Landscape Amid the COVID-19 crisis, the global Botulinum Toxin market is estimated to reach USD 9442.93 Million by 2025. In the future,…
read more